Future-proof your body with the healing cells you already have today.
Ever wish you could freeze time and stay as healthy as you are right now? With stem cell banking, you can be one step closer to that dream. By banking your stem cells at American Cell Technology (ACT), you’re taking a proactive step toward a healthier future.
Consider this: As we age, the likelihood of encountering health challenges drastically increases. By age 65, approximately 80% of Americans develop chronic conditions that could potentially benefit from regenerative medicine.1 With millions affected by conditions like arthritis, heart disease, and diabetes, stem cell therapy offers significant potential in combating these future health crises.
The Science of Self: What Makes Your Own Cells So Powerful
The power behind stem cells, particularly mesenchymal stem cells (MSCs) found in your fat tissue and bone marrow, is their ability to develop into various cell types in your body, including muscle, bone, fat, cartilage, and more. These remarkable cells do more than just transform, they also release over 200 bioactive factors that reduce inflammation, promote tissue repair, and modulate immune responses.
Think of your stem cells as your body’s natural repair kit – actively working to reduce inflammation, regenerate tissue, and help you bounce back from life’s challenges. By banking these potent cells with ACT while they are young and healthy, you’re essentially locking in their optimal potential, safeguarding yourself against the effects of aging and environmental stressors.
How it Works: Behind-the-Scenes of Preservation
Once ACT receives your sample, they employ state-of-the-art cryopreservation techniques to ensure their long-term viability. This process involves carefully and gradually cooling your cells to ultra-low temperatures, typically around -190°C (-310°F) using liquid nitrogen. At these temperatures, all biological activity, including aging, essentially halts, effectively “freezing time” for your cells.
ACT’s advanced storage facilities maintain these precise conditions with continuous monitoring and robust security systems, providing a safe and stable environment for your precious cells for decades. To learn more about this meticulous process, watch the behind-the-scenes video here.
A Gift to Your Future Self
Case Study: Michael’s Foresight – A Testament to the Value of Stem Cell Banking Michael, 42, made the proactive decision to bank his stem cells with American Cell Technology after witnessing his father’s struggle with a debilitating arthritis. “I was still active and healthy, but I could see what might be coming,” he explains. Three years later, when Michael experienced a severe knee injury that wasn’t responding to conventional treatment, his orthopedic specialist was able to use his banked cells as part of his treatment plan. “Having access to my own younger, healthier cells made a tremendous difference in my recovery time and outcome,” Michael shares. This is the peace of mind and potential for enhanced recovery that American Cell Technology offers.
Unmatched Safety, Unparalleled Potential: The Autologous Advantage
Choosing to bank your own adult stem cells (autologous use) with ACT offers a significant safety advantage. Because the cells are a perfect genetic match, the risk of immune rejection is virtually eliminated. In contrast, using stem cells from a donor (allogeneic use) carries a higher risk of complications due to the foreign DNA, potentially leading to immune system rejection and the need for immunosuppressant drugs. The safety of autologous stem cell banking reinforces the value of investing in your own cells for future therapeutic needs through American Cell Technology.
Ready to Invest in Your Future Health? Don’t wait for a health scare. Bank your healthiest cells now — future you will thank you.
Contact ACT today for more info!
(844) 443-2355
info@americancelltechnology.com
References:
- Fontana, L. (2009). Modulating human aging and age-associated diseases. Biochimica et Biophysica Acta (BBA) – General Subjects, 1790(10), 1133–1138. https://doi.org/10.1016/j.bbagen.2009.02.002
